- Home
- VYGR vs MFH Comparison
VYGR vs MFH Comparison
Compare VYGR & MFH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VYGR
- MFH
- Stock Information
- Founded
- VYGR 2013
- MFH 2011
- Country
- VYGR United States
- MFH United States
- Employees
- VYGR N/A
- MFH N/A
- Industry
- VYGR Biotechnology: Pharmaceutical Preparations
- MFH Finance: Consumer Services
- Sector
- VYGR Health Care
- MFH Finance
- Exchange
- VYGR Nasdaq
- MFH Nasdaq
- Market Cap
- VYGR 222.9M
- MFH 382.7M
- IPO Year
- VYGR 2015
- MFH N/A
- Fundamental
- Price
- VYGR $3.12
- MFH $4.80
- Analyst Decision
- VYGR Strong Buy
- MFH
- Analyst Count
- VYGR 9
- MFH 0
- Target Price
- VYGR $14.86
- MFH N/A
- AVG Volume (30 Days)
- VYGR 392.6K
- MFH 63.4K
- Earning Date
- VYGR 05-12-2025
- MFH 04-21-2025
- Dividend Yield
- VYGR N/A
- MFH N/A
- EPS Growth
- VYGR N/A
- MFH N/A
- EPS
- VYGR N/A
- MFH N/A
- Revenue
- VYGR $80,001,000.00
- MFH $716,863.00
- Revenue This Year
- VYGR N/A
- MFH N/A
- Revenue Next Year
- VYGR $2.04
- MFH N/A
- P/E Ratio
- VYGR N/A
- MFH N/A
- Revenue Growth
- VYGR N/A
- MFH 119.50
- 52 Week Low
- VYGR $3.10
- MFH $1.03
- 52 Week High
- VYGR $9.66
- MFH $8.86
- Technical
- Relative Strength Index (RSI)
- VYGR 24.97
- MFH 37.49
- Support Level
- VYGR $3.26
- MFH $5.28
- Resistance Level
- VYGR $3.52
- MFH $6.27
- Average True Range (ATR)
- VYGR 0.21
- MFH 0.64
- MACD
- VYGR -0.04
- MFH -0.02
- Stochastic Oscillator
- VYGR 0.94
- MFH 0.00
About VYGR Voyager Therapeutics Inc.
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.
About MFH Mercurity Fintech Holding Inc.
Mercurity Fintech Holding Inc is a New York-based digital fintech leader providing access to the rapidly growing AI-powered infrastructure, blockchain, and digital assets sectors. Its three core business lines include: 1. Blockchain and digital asset solutions. 2. AI and HPC infrastructure, specializing in developing liquid cooling solutions for AI data centers. 3. Comprehensive financial services.